000			02009 a2200601 4500
005			20250516220329.0
264		0	_c20141006
008			201410s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/bjc.2014.327 _2doi
040			_aNLM _beng _cNLM
100	1		_aPeiró, G
245	0	0	_aSrc, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. _h[electronic resource]
260			_bBritish journal of cancer _cAug 2014
300			_a689-95 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Humanized _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCentral Nervous System Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClass I Phosphatidylinositol 3-Kinases
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEnzyme Activation
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aPhosphatidylinositol 3-Kinases _xgenetics
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aTrastuzumab
650	0	4	_asrc-Family Kinases _xantagonists & inhibitors
700	1		_aOrtiz-Martínez, F
700	1		_aGallardo, A
700	1		_aPérez-Balaguer, A
700	1		_aSánchez-Payá, J
700	1		_aPonce, J J
700	1		_aTibau, A
700	1		_aLópez-Vilaro, L
700	1		_aEscuin, D
700	1		_aAdrover, E
700	1		_aBarnadas, A
700	1		_aLerma, E
773	0		_tBritish journal of cancer _gvol. 111 _gno. 4 _gp. 689-95
856	4	0	_uhttps://doi.org/10.1038/bjc.2014.327 _zAvailable from publisher's website
999			_c23926788 _d23926788